Prediabetes encompasses wide-ranging metabolic dysfunction beyond isolated glucose intolerance, complicating uniform risk assessment and intervention strategies across heterogeneous patient populations.
In the study published in the Cardiovascular Diabetology, the investigators analyzed 79,000 individuals from three large-scale prospective Chinese cohorts. They partitioned participants into six profiles capturing 70% of the prediabetes spectrum through five metabolically distinct clusters alongside one featureless group, establishing baseline cardiometabolic burden gradients alongside longitudinal progression risks toward type 2 diabetes, cardiovascular disease, and chronic kidney disease events. 
Six Profiles Capture Metabolic Heterogeneity
Hypertensive phenotype characterized by elevated blood pressure demonstrated highest absolute risk elevation, with 20% increased membership probability associating with 9% higher type 2 diabetes incidence, 6% cardiovascular disease risk increment, and 12% chronic kidney disease hazard ratio elevation over median follow-up. Lipid-creatinine-liver enzyme profile exhibited parallel 10% risk amplification for both diabetes progression and kidney outcomes.
Divergent Progression Trajectories by Phenotype
Lower-risk profiles manifested isolated mild glucose dysregulation with minimal visceral adiposity, contrasting sharply with multi-trait clusters combining dysglycemia, atherogenic dyslipidemia, hepatic insulin resistance signatures, and glomerular filtration rate decline precursors. Featureless profile represented regression toward normoglycemia or artifactual prediabetes ascertainment.
Phenotype Probabilities Enhance Predictive Models
Integration of continuous phenotypic probabilities into established risk calculators yielded statistically significant discrimination improvement through likelihood ratio testing across all endpoints, establishing superior net reclassification versus traditional fasting glucose or HbA1c thresholds alone. 
Precision Prevention Through Subgroup Targeting
Endocrinologists and primary care physicians gain actionable framework facilitating phenotype-specific intervention algorithms beyond generic lifestyle counseling for all prediabetes labels. Hypertensive profile patients require concurrent blood pressure optimization alongside metformin initiation targeting dual diabetes-cardiovascular prevention, while lipid-centric phenotypes benefit from early statin therapy paralleling sodium-glucose cotransporter-2 inhibitors for kidney protection. Serial phenotyping tracks therapeutic trajectory modification, identifying persistent high-risk membership despite glycemic normalization.
Implementation Within Routine Screening Protocols
Embedding uniform manifold approximation and projection-derived calculators within electronic health record systems automates phenotype probability generation from routine lipid panels, liver enzymes, creatinine, and blood pressure measurements obtained during annual wellness visits. Population health dashboards stratify prediabetes cohorts into intervention tiers maximizing yield through targeted pharmacotherapy enrollment and intensive lifestyle cohorts.